RESOURCE USE AND ASSOCIATED COSTS FOR METASTATIC SQUAMOUS NON SMALL CELL LUNG CANCER (SQ NSCLC) PATIENTS: A RETROSPECTIVE CHART REVIEW IN SELECT EUROPEAN COUNTRIES

被引：0
|
作者：
Lorenzo, M. [1 ]
Brown, J. [1 ]
Kurosky, S. [2 ]
Ajmera, M. R. [2 ]
Kaye, J. A. [3 ]
机构：
[1] Eli Lilly & Co Ltd, Windlesham, Surrey, England
[2] RTI Hlth Solut, Res Triangle Pk, NC USA
[3] RTI Hlth Solut, Waltham, MA USA
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
10.1016/j.jval.2016.09.2333
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN257
引用
收藏
页码：A755 / A755
页数：1
相关论文
共 50 条
  • [41] Survival rates in non-selected consecutive patients with advanced and metastatic non-small cell lung cancer (NSCLC):: A retrospective analysis from a lung cancer center
    Martens, U
    Bludau, P
    Kaiser, P
    Mönting, JS
    Digel, W
    LUNG CANCER, 2005, 49 : S257 - S258
  • [42] Costs of Adverse Events (AE) Associated with Cancer Therapies in Non-Small Cell Lung Cancer (NSCLC) in France
    Chouaid, Christos
    Loirat, Delphine
    Godard, Chloe
    Clay, Emilie
    Millier, Aurelie
    Levy-Bachelot, Laurie
    Angevin, Eric
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S693 - S693
  • [43] Predictors of radiation therapy (RT) use among Medicare patients with metastatic non-small cell lung cancer (NSCLC)
    Kim, Miranda
    Schrag, Deborah
    Li, Ling
    Chen, Aileen B.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (29)
  • [44] Comorbidity in clinical trial patients with advanced or metastatic non-small cell lung cancer (NSCLC).
    Kosov, Maxim
    Kumar, Akhil
    Belotserkovskiy, Maxim
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [45] Effect of primary tumor size in patients with metastatic non-small cell lung cancer (NSCLC).
    Xia, Bing
    Gao, Feng
    Govindan, Ramaswamy
    Morgensztern, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [46] Screening for mutations in Colombian metastatic non-small cell lung cancer (NSCLC) patients (ONCOLGroup).
    Cardona, A. F.
    Ramos, P. L.
    Duarte, R.
    Carranza, H.
    Castro, C. J.
    Lema, M.
    Vargas, C. A.
    Jimenez, A.
    Becerra, H. A.
    Rosell, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [47] Regional retrospective analysis of outcomes of EGFR mutated non-squamous non-small cell lung cancer (NSCLC) patients in West Yorkshire
    Sharma, D.
    Slevin, F.
    Clarke, K.
    Franks, K.
    Snee, M.
    Jain, P.
    ANNALS OF ONCOLOGY, 2019, 30
  • [48] SCREENING FOR MUTATIONS IN COLOMBIAN METASTATIC NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENTS (ONCOLGROUP)
    Cardona, Andres F.
    Serrano, Silvia J.
    Ramos, Pedro L.
    Duarte, Ricardo
    Carranza, Hernan
    Castro, Carlos J.
    Lema, Mauricio
    Vargas, Carlos A.
    Jimenez, Juan A.
    Archila, Pilar
    Salazar, Ruben D.
    Torres, Diana
    Bruges, Ricardo E.
    Guerra, Joaquin
    Urrego, Marcela
    Becerra, Henry A.
    Bonilla, Carlos
    Rosell, Rafael
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S963 - S963
  • [49] Factors associated with time to EGFR TKI treatment in patients with non-squamous metastatic non-small-cell lung cancer
    Marrett, Elizabeth
    Kwong, Winghan Jacqueline
    Chow, Laura Q. M.
    FUTURE ONCOLOGY, 2022, 18 (13) : 1535 - 1544
  • [50] Real world treatment patterns, healthcare resource use and costs in patients with advanced or metastatic non-small cell lung cancer by EGFR mutation type
    Vadagam, Pratyusha
    Waters, Dexter
    Lee, Inyoung
    Chen, Justin
    Tian, Dajun
    Near, Aimee M.
    Lyle, Derek
    Vanderpoel, Julie
    JOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) : 219 - 229
12345